New important compounds for targeted and immunotherapies for lung cancer

Share :
Published: 7 Aug 2018
Views: 2238
Rating:
Save
Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA

Dr Rolfo speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about new compounds for targeted therapy and immunotherapy.

These include new compounds found in RET, ALK and ROS.

He also discusses the new compounds in immunotherapy, one specifically, an anti PD-L1 for TGF-β in HBB tumours.

Dr Rolfo finishes on a reminder that we need to test all the patients for driver mutations before starting immunotherapy.